 |
|
|
| |
Ledipasvir/Sofosbuvir+/-Ribavirin in Patients Co-infected with HCV and HIV:
Real-world Heterogeneous Population from the TRIO Network
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Douglas T. Dieterich1, Bruce Bacon2, Michael Curry3, Steven L. Flamm4, Lauren Guest5, Kris Kowdley6, YooriLee5, ZobairYounossi7, NaokyTsai8, and NezamAfdhal3
1Icahn School of Medicine at Mount Sinai, 2Saint Louis University School of Medicine,3Beth Israel Deaconess Medical Center, 4Northwestern University Feinberg School of Medicine,5Trio Health Analytics,
6Liver Care Network, Swedish Medical Center, 7Center for Liver Diseases, Department of Medicine, InovaFairfax Hospital, and 8Queens Medical Center, University of Hawaii
|
| |
|
|
|
|
|
